INGLIS TIFFANY EUL DAVIS (Chief Medical Officer) sold 0.5% of their position (486.00 shares) of SERA PROGNOSTICS, INC. on the open market
Open‑market sale worth $972.00 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/11/2026ACC: 0002091798-26-000008
Officer· Chief Medical Officer
Since Mar 2026
-486.00
Net shares
Net seller
$972.00
Total sold
1
Open market trades
0B · 1S
1
Total transactions
486.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−486.00
Price / share
$2.00
Trade value
$972.00
% of position
0.5%
9/10/2026
92.08K→91.59K
Total
Net shares
−486.00
Net value
-$972.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/10/2026 | S · Sale | −486.00 | $2.00 | $972.00 | 0.5% | 92.08K | 91.59K |
| Total | −486.00 | -$972.00 | ||||||
Derivative Transactions0
No derivative transactions reported